A detailed history of Snowden Capital Advisors LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 5,143 shares of ILMN stock, worth $532,660. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,143
Previous 5,706 9.87%
Holding current value
$532,660
Previous $595,000 12.61%
% of portfolio
0.02%
Previous 0.02%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$105.28 - $135.9 $59,272 - $76,511
-563 Reduced 9.87%
5,143 $670,000
Q2 2024

Aug 14, 2024

BUY
$101.05 - $133.57 $171,582 - $226,801
1,698 Added 42.37%
5,706 $595,000
Q1 2024

May 15, 2024

BUY
$127.73 - $147.2 $86,984 - $100,243
681 Added 20.47%
4,008 $550,000
Q4 2023

Feb 14, 2024

SELL
$92.79 - $142.53 $248,306 - $381,410
-2,676 Reduced 44.58%
3,327 $463,000
Q3 2023

Nov 14, 2023

BUY
$128.91 - $192.44 $23,074 - $34,446
179 Added 3.07%
6,003 $824,000
Q2 2023

Aug 14, 2023

SELL
$183.43 - $232.67 $12,289 - $15,588
-67 Reduced 1.14%
5,824 $1.09 Million
Q1 2023

May 15, 2023

BUY
$193.75 - $232.55 $190,068 - $228,131
981 Added 19.98%
5,891 $1.37 Million
Q4 2022

Feb 13, 2023

BUY
$187.24 - $242.74 $274,306 - $355,614
1,465 Added 42.53%
4,910 $992,000
Q3 2022

Nov 09, 2022

BUY
$177.23 - $227.44 $58,308 - $74,827
329 Added 10.56%
3,445 $657,000
Q2 2022

Aug 12, 2022

BUY
$181.58 - $368.0 $261,656 - $530,288
1,441 Added 86.03%
3,116 $574,000
Q1 2022

May 16, 2022

BUY
$303.87 - $423.8 $427,545 - $596,286
1,407 Added 525.0%
1,675 $585,000
Q4 2021

Feb 14, 2022

BUY
$347.28 - $421.83 $93,071 - $113,050
268 New
268 $101,000
Q3 2021

Feb 05, 2024

SELL
$405.61 - $524.84 $1.72 Million - $2.23 Million
-4,250 Reduced 70.8%
1,753 $711 Million
Q2 2021

Jan 08, 2024

BUY
$372.84 - $481.5 $26,844 - $34,668
72 Added 4.27%
1,757 $831 Million
Q1 2021

Jan 08, 2024

SELL
$361.28 - $504.76 $2.62 Million - $3.67 Million
-7,265 Reduced 81.17%
1,685 $647 Million
Q4 2020

Jan 08, 2024

BUY
$292.7 - $370.96 $213,378 - $270,429
729 Added 8.87%
8,950 $3.31 Billion
Q3 2020

Jan 08, 2024

BUY
$268.51 - $400.74 $91,293 - $136,251
340 Added 4.31%
8,221 $2.54 Billion
Q2 2020

Jan 08, 2024

BUY
$256.46 - $373.01 $148,746 - $216,345
580 Added 7.94%
7,881 $2.92 Billion
Q1 2020

Jan 08, 2024

SELL
$209.2 - $335.53 $252,713 - $405,320
-1,208 Reduced 14.2%
7,301 $1.99 Billion
Q4 2019

Jan 30, 2024

BUY
$288.29 - $335.49 $954,528 - $1.11 Million
3,311 Added 63.7%
8,509 $2.82 Billion
Q4 2019

Jan 08, 2024

BUY
$288.29 - $335.49 $954,528 - $1.11 Million
3,311 Added 63.7%
8,509 $2.82 Billion
Q3 2019

Jan 30, 2024

SELL
$266.84 - $378.23 $866,429 - $1.23 Million
-3,247 Reduced 38.45%
5,198 $1.58 Billion
Q3 2019

Jan 08, 2024

SELL
$266.84 - $378.23 $3.4 Million - $4.81 Million
-12,729 Reduced 71.0%
5,198 $1.58 Billion
Q2 2019

Jan 30, 2024

BUY
$300.59 - $368.15 $734,040 - $899,022
2,442 Added 40.68%
8,445 $3.11 Billion
Q2 2019

Jan 08, 2024

BUY
$300.59 - $368.15 $2.92 Million - $3.58 Million
9,723 Added 118.52%
17,927 $3.13 Billion
Q1 2019

Jan 08, 2024

BUY
$272.57 - $321.18 $133,831 - $157,699
491 Added 6.37%
8,204 $2.55 Billion
Q4 2018

Jan 08, 2024

BUY
$272.46 - $366.54 $319,050 - $429,218
1,171 Added 17.9%
7,713 $2.31 Billion
Q3 2018

Jan 08, 2024

BUY
$279.04 - $367.06 $311,408 - $409,638
1,116 Added 20.57%
6,542 $2.4 Billion
Q2 2018

Jan 08, 2024

BUY
$228.17 - $292.07 $76,208 - $97,551
334 Added 6.56%
5,426 $1.52 Billion
Q1 2018

Jan 08, 2024

BUY
$209.54 - $253.91 $77,320 - $93,692
369 Added 7.81%
5,092 $1.2 Billion
Q4 2017

Jan 08, 2024

BUY
$202.23 - $230.03 $89,790 - $102,133
444 Added 10.38%
4,723 $1.03 Billion
Q3 2017

Jan 08, 2024

BUY
$172.3 - $213.93 $62,717 - $77,870
364 Added 9.3%
4,279 $852 Million
Q2 2017

Jan 08, 2024

BUY
N/A
3,915 New
3,915 $679 Million
Q4 2016

Jan 08, 2024

SELL
N/A
-12,170 Closed
0 $0
Q3 2016

Jan 08, 2024

BUY
N/A
6,167
12,170 $2.21 Billion

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $16.3B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.